Clinical Trials in New York

Showing 4641-4660 of 17,259 trials

A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

NCT03983382

The purpose of this study is to test whether patients with breast cancer who are being treated with non-anthracycline trastuzumab therapy can safely be monitored for heart related side effects less often than usual.

Breast Cancer

Memorial Sloan Kettering Cancer Center190 participantsStarted Mar 2019

Hartford, Connecticut, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +5 more locations

COMPLETEDNA< 1 mile

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

NCT06136936

An exploratory, double-arm, 4-week study to explore the feasibility and acceptability of abbreviated treatment with CT-156 for people with Schizophrenia.

Schizophrenia

Click Therapeutics, Inc.53 participantsStarted Sep 2023

New York, New York, United States

Active Not Recruiting< 1 mile

Collecting Dietary Information From People Undergoing Cancer Treatment

NCT05404009

The purpose of this study is to develop a secure method of collecting dietary and nutritional intake information from people with cancer. The researchers will use this information to learn more about how dietary information may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.

Receiving Allogeneic Hematopoietic Cell Transplants

Memorial Sloan Kettering Cancer Center150 participantsStarted May 2022

New York, New York, United States

A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

Collecting Dietary Information From People Undergoing Cancer Treatment

Find Trials by Condition in New York

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Study of AGEN1571 in Participants With Advanced Solid Tumors

ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

DMD Voice: Qualitative Interviews With Patients and Caregivers

Targeting Attention Orienting to Social Threat to Reduce Social Anxiety in Youth

Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Promoting Early Intervention Timing and Attention to Language

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

A Digital Intervention to Improve Physical Activity and Sleep Behaviors in Youth With Psychiatric Diagnoses

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

An Investigation to Validate Speech Perception Assessment for Adult Cochlear Recipients Using a Mobile Research App